| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HUMANIGEN, INC | Director | Stock Option (Right to Buy) | 73,307 | $208,192 | $2.84 | 27 Jul 2022 | Direct |
| Omega Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 25,000 | 20 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OMGAQ | Omega Therapeutics, Inc. | 20 Jun 2024 | 1 | $0 | 4 | Director | 21 Jun 2024, 16:20 |
| OMGAQ | Omega Therapeutics, Inc. | 07 Jun 2023 | 1 | $0 | 4 | Director | 09 Jun 2023, 16:05 |
| OMGAQ | Omega Therapeutics, Inc. | 31 Aug 2022 | 1 | $0 | 4 | Director | 01 Sep 2022, 16:27 |
| OMGAQ | Omega Therapeutics, Inc. | 31 Aug 2022 | 0 | $0 | 3 | Director | 01 Sep 2022, 16:25 |
| /report/000121465922009387-boehm-rainer-j-2022-07-27 | HUMANIGEN, INC | 27 Jul 2022 | 1 | $0 | 4 | Director | 29 Jul 2022, 18:30 |
| /report/000121465922000270-boehm-rainer-j-2021-12-31 | HUMANIGEN, INC | 31 Dec 2021 | 1 | +$14,532 | 4 | Director | 04 Jan 2022, 17:20 |